[HTML][HTML] Alzheimer's disease pharmacotherapy in relation to cholinergic system involvement

GD Stanciu, A Luca, RN Rusu, V Bild… - Biomolecules, 2019 - mdpi.com
Alzheimer's disease, a major and increasing global health challenge, is an irreversible,
progressive form of dementia, associated with an ongoing decline of brain functioning. The …

Seaweeds: A sustainable functional food for complementary and alternative therapy

S Mohamed, SN Hashim, HA Rahman - Trends in food science & …, 2012 - Elsevier
Edible seaweeds are rich in bioactive antioxidants, soluble dietary fibers, proteins, minerals,
vitamins, phytochemicals, and polyunsaturated fatty acids. Although previously the …

A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease

P Anand, B Singh, N Singh - Bioorganic & medicinal chemistry, 2012 - Elsevier
Acetylcholinesterase (AChE) enzyme inhibition is an important target for the management of
Alzheimer disease (AD) and AChE inhibitors are the main stay drugs for its management …

The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease

S Habtemariam - Evidence‐based Complementary and …, 2016 - Wiley Online Library
Rosemary (Rosmarinus officinalis L.) is one of the most economically important species of
the family Lamiaceae. Native to the Mediterranean region, the plant is now widely distributed …

[PDF][PDF] Cholinesterases, a target of pharmacology and toxicology.

M Pohanka - Biomedical Papers of the Medical Faculty of …, 2011 - pdfs.semanticscholar.org
Background. Cholinesterases are a group of serine hydrolases that split the neurotransmitter
acetylcholine (ACh) and terminate its action. Of the two types, butyrylcholinesterase and …

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus

G Mushtaq, NH Greig, JA Khan… - CNS & Neurological …, 2014 - ingentaconnect.com
Both Alzheimer's disease (AD) and Type 2 diabetes mellitus (T2DM) share the presence of
systemic and neuro-inflammation, enhanced production and accumulation of β-amyloid …

Cholinergic system during the progression of Alzheimer's disease: therapeutic implications

EJ Mufson, SE Counts, SE Perez… - Expert review of …, 2008 - Taylor & Francis
Alzheimer's disease (AD) is characterized by a progressive phenotypic downregulation of
markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced …

Targeting acetylcholinesterase and butyrylcholinesterase in dementia

RM Lane, SG Potkin, A Enz - International Journal of …, 2006 - academic.oup.com
Abstract The cholinesterase inhibitors (ChE-Is) attenuate the cholinergic deficit underlying
the cognitive and neuropsychiatric dysfunctions in patients with AD. Inhibition of brain …

The concise guide to PHARMACOLOGY 2013/14: enzymes

SPH Alexander, HE Benson… - British Journal of …, 2013 - Wiley Online Library
Abstract The Concise Guide to PHARMACOLOGY 2013/14 provides concise overviews of
the key properties of over 2000 human drug targets with their pharmacology, plus links to an …

Cellular and molecular actions of methylene blue in the nervous system

M Oz, DE Lorke, M Hasan… - Medicinal research …, 2011 - Wiley Online Library
Methylene Blue (MB), following its introduction to biology in the 19th century by Ehrlich, has
found uses in various areas of medicine and biology. At present, MB is the first line of …